rediff News http://www.rediff.com/tags/eisai India's largest news and entertainment service online.. en-us Fri, 31 Jul 15 11:31:38 +0000 Fri, 31 Jul 15 11:31:38 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Lupin launches generic GERD drug in the US market]]> http://www.rediff.com/money/report/lupin-launches-generic-gerd-drug-in-the-us-market/20131111.htm Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Eisai to invest $44 mn in India]]> http://www.rediff.com/money/report/eisai/20060504.htm Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Dr Reddy's launch generic cancer drug in US market]]> http://www.rediff.com/money/report/dr-reddys-launch-generic-cancer-drug-in-us-market/20130712.htm Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[GSK to make India a hub for anti-parasite drugs]]> http://www.rediff.com/money/report/gsk--make-india-hub-for-anti-parasite-drugs/20101015.htm Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Ranbaxy gets US nod to sell Alzheimer's generic]]> http://www.rediff.com/money/report/ranbaxy-gets-us-nod-to-sell-alzheimers-generic/20100922.htm Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Continuation of "Policy for Protection of The Company's Corporate Value and Common Interests of Shareholders (Shareholder Rights Plan)"]]> http://in.sys-con.com/node/3393097 Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Eisai seeks simultaneous approval for anticancer agent in Japan, US and Europe]]> http://www.biospectrumasia.com/biospectrum/news/222042/eisai-seeks-simultaneous-approval-anticancer-agent-japan-us-europe?WT.rss_f=Home&WT.rss_a=Eisai+seeks+simultaneous+approval+for+anticancer+agent+in+Japan%2C+US+and+Europe+ Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Eisai and Halozyme Sign Collaboration Agreement to Investigate HalavenĀ® (Eribulin) and PEGPH20 in Metastatic..]]> http://in.advfn.com/p.php?pid=nmona&article=67961097 Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Nikkei flat as investors await more blue-chip earnings; fret over China]]> http://economictimes.indiatimes.com/markets/stocks/news/nikkei-flat-as-investors-await-more-blue-chip-earnings-fret-over-china/articleshow/48290205.cms Fri, 31 Jul 2015 17:01:38 +0530 <![CDATA[Eisai Submits Applications for a New Indication in the U.S., Japan and EU for HalavenĀ® (Eribulin) in Soft Tissue Sarcoma]]> http://in.sys-con.com/node/3392914 Fri, 31 Jul 2015 17:01:38 +0530